Literature DB >> 23810548

Pediatric peritonsillar abscess: Quinsy ie versus interval tonsillectomy.

Lawrence M Simon1, Jackie West-Denning Matijasec, Alvin P Perry, Anagha Kakade, Rohan R Walvekar, Evelyn A Kluka.   

Abstract

PERITONSILLAR ABSCESS: Quinsy versus interval tonsillectomy. OBJECTIVES STUDY
DESIGN: Case series with chart review.
METHODS: We reviewed the records of children treated for peritonsillar abscess between 2007 and 2011 at an academic tertiary pediatric hospital. We identified patients by searching the hospital database for all children treated for the ICD-9 code 475 (peritonsillar abscess). Data points extracted included length of stay, intraoperative blood loss, operative time, and incidence of complications. Statistical analysis was performed to identify significant differences between treatment categories. Children who never received a tonsillectomy (CPT codes 42820/42821/42825/42826) were excluded.
RESULTS: 34 children received tonsillectomy for peritonsillar abscess from 2007 to 2011. Of these: 23 received a Quinsy tonsillectomy, and 11 received antibiotics with or without incision and drainage, followed by tonsillectomy a minimum of 2 weeks later. Total hospital days in treatment course was 2.2 days for Quinsy tonsillectomy group and 2.3 days for the interval tonsillectomy group. Estimated blood loss was less than 20 ml for both groups. Operative time was 38 min for Quinsy tonsillectomy and 39 min for interval tonsillectomy. There were no post-tonsillectomy hemorrhages. One patient in the interval tonsillectomy group required readmission for dehydration.
CONCLUSION: There were no significant differences in total hospital days, blood loss, operative time, or post-operative complications between Quinsy tonsillectomy and interval tonsillectomy in the treatment of pediatric peritonsillar abscess.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Peritonsillar abscess; Quinsy tonsillectomy; Tonsillectomy

Mesh:

Substances:

Year:  2013        PMID: 23810548     DOI: 10.1016/j.ijporl.2013.05.034

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Implication of Fusobacterium necrophorum in recurrence of peritonsillar abscess.

Authors:  S Ahmed Ali; Kevin J Kovatch; Josh Smith; Emily L Bellile; John E Hanks; Paul T Hoff
Journal:  Laryngoscope       Date:  2018-12-24       Impact factor: 3.325

2.  Patients with comorbid rheumatoid arthritis are predisposed to peritonsillar abscess: real-world evidence.

Authors:  Meng-Chang Ding; Ming-Shao Tsai; Yao-Hsu Yang; Chia-Yen Liu; Yao-Te Tsai; Cheng-Ming Hsu; Ching-Yuan Wu; Pey-Jium Chang; Ko-Ming Lin; Geng-He Chang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-03       Impact factor: 2.503

3.  Hospital discharge survey on 4,199 peritonsillar abscesses in the Veneto region: what is the risk of recurrence and complications without tonsillectomy?

Authors:  R Bovo; M R Barillari; A Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-11       Impact factor: 2.503

4.  Clinical practice guideline: tonsillitis II. Surgical management.

Authors:  Jochen P Windfuhr; Nicole Toepfner; Gregor Steffen; Frank Waldfahrer; Reinhard Berner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

5.  High Risk of Peritonsillar Abscess in End-Stage Renal Disease Patients: A Nationwide Real-World Cohort Study.

Authors:  Geng-He Chang; Ang Lu; Yao-Hsu Yang; Chia-Yen Liu; Pey-Jium Chang; Chuan-Pin Lee; Yao-Te Tsai; Cheng-Ming Hsu; Ching-Yuan Wu; Wei-Tai Shih; Ming-Shao Tsai
Journal:  Int J Environ Res Public Health       Date:  2021-06-24       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.